Zhiyi Zhou
Chongqing, 401147, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A therapeutic relay strategy enabled by spatiotemporally programmable nanoplatforms for multilayered cardioprotection against MI/RI.
Journal: Journal of nanobiotechnology
Published: January 26, 2026
Igniting Endogenous Calcipoptosis via ER-Mitochondrial Calcium Shuttle Hijacking for Potent Antitumor Immunity.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: September 23, 2025
Correlation between obesity-related indices and hypertension.
Journal: American journal of translational research
Published: April 28, 2024
Self-Reinforced Bimetallic Mito-Jammer for Ca2+ Overload-Mediated Cascade Mitochondrial Damage for Cancer Cuproptosis Sensitization.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 24, 2023
Tumor-penetrating nanoplatform with ultrasound "unlocking" for cascade synergistic therapy and visual feedback under hypoxia.
Journal: Journal of nanobiotechnology
Published: October 13, 2022
NIR Activated Multimodal Therapeutics Based on Metal-Phenolic Networks-Functionalized Nanoplatform for Combating against Multidrug Resistance and Metastasis.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: October 08, 2022
Peptide Supramolecular Assembly-Instructed In Situ Self-Aggregation for Stratified Targeting Sonodynamic Therapy Enhancement of AIE Luminogens.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 30, 2022
Low Intensity Focused Ultrasound Ignited "Deep-Penetration Nanobomb" (DPNB) for Tetramodal Imaging Guided Hypoxia-Tolerant Sonodynamic Therapy Against Hypoxic Tumors.
Journal: International journal of nanomedicine
Published: February 22, 2022
Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy.
Journal: Theranostics
Published: February 04, 2022
Amplified antitumor efficacy by a targeted drug retention and chemosensitization strategy-based "combo" nanoagent together with PD-L1 blockade in reversing multidrug resistance.
Journal: Journal of nanobiotechnology
Published: May 05, 2021
Last Updated: 09/26/2026